Schrimer test in Parkinson's disease

Area of Science:

• Neurology
• Ophthalmology

Background:

• Parkinson's disease is a neurodegenerative disorder affecting motor control.
• Autonomic dysfunction and emotional disturbances are common in Parkinson's disease.
• Lacrimation plays a role in ocular health and comfort.

Purpose of the Study:

• To objectively measure and compare lacrimation levels in Parkinson's disease patients and age-matched controls.
• To investigate the potential association between reduced lacrimation and Parkinson's disease.

Main Methods:

• The Schirmer test was employed to quantify tear production.
• Standardized Whatman No. 2 paper strips were used for measurement.
• Tear secretion was assessed over a five-minute period in 51 Parkinson's patients and 75 controls.

Main Results:

• Parkinson's disease patients exhibited significantly lower lacrimation (3.4 +/- 2.3mm) compared to controls (8.1 +/- 6.5mm).
• The difference in lacrimation between the groups was statistically significant (p < 0.01).

Conclusions:

• Reduced lacrimation is a measurable finding in Parkinson's disease.
• This decrease may be linked to autonomic dysfunction and emotional changes associated with the disease.
• The basal ganglia's potential role in regulating lacrimation is suggested, with connections to the limbic system and superior salivatory nucleus.